The relationship between the number of available therapeutic options and government payer (medicare part D) spending on topical drug products

作者：Michael Kwa, Kyle Tegtmeyer, Leah J. Welty, Sam G. Raney, Markham C. Luke, Shuai Xu, Betty Y. Kong · 发表于：Archives of Dermatological Research · 年份：2020 · DOI：10.1007/s00403-020-02042-9 · 被引用次数：6 · 研究领域：Pharmaceutical Economics and Policy、Pharmaceutical industry and healthcare、Health Systems, Economic Evaluations, Quality of Life